Keystone Symposia

Fairmont Banff Springs Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2017


Here are the related meetings in 2020:
Noncoding RNAs: Mechanism, Function and Therapies (A1)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Noncoding RNAs: From Disease to Targeted Therapeutics (J5)


Organizer(s) Kevin V. Morris, Archa Fox and Paloma Hoban Giangrande
February 5—9, 2017
Fairmont Banff Springs • Banff, AB Canada
Discounted Abstract Deadline: Oct 5, 2016
Abstract Deadline: Nov 2, 2016
Scholarship Deadline: Oct 5, 2016
Discounted Registration Deadline: Dec 6, 2016

Sponsored by Cell Research, Ionis Pharmaceuticals, Inc. Merck & Co., Inc. and Moderna Therapeutics


Summary of Meeting:
It has become apparent over the last decade that small and long noncoding RNAs play a major role in the regulation of gene expression and disease. While much emphasis has been centered on the role of noncoding RNAs in human disease, a gap remains in utilizing this knowledge to develop target specific approaches to disrupting noncoding RNA pathways for therapeutic gain. This meeting will for the first time bring together an interdisciplinary group of basic and applied noncoding RNA scientists in an effort to translate our current understanding of noncoding RNA biology into meaningful therapeutics for many of those diseases afflicting society. To accomplish this goal, the meeting will aim to: (1) Introduce the broad genome-wide basic fabric of noncoding RNA regulation and form and function in the cell; (2) Focus on direct RNA/chromatin/DNA or RNA/protein interactions with candidate disease-relevant model systems; and (3) Highlight synthetic biological approaches to developing RNA or oligonucleotide mimics to target and/or disrupt particular disease-relevant noncoding RNA pathways. The goal of this meeting is to bring together basic and applied scientists working on noncoding RNAs in an effort to not only better understand the role noncoding RNAs play in the regulation of disease-relevant genes but also the emerging ability to utilize this knowledge to develop targeted therapeutics, an eventuality that heralds a new frontier in drug development and therapeutics.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, February 5 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 9 with a closing plenary session from 17:00 to 19:15, followed by a social hour and entertainment. We recommend return travel on Friday, February 10 in order to fully experience the meeting.

SUNDAY, FEBRUARY 5

16:00—20:00
Arrival and Registration

Van Horne Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Van Horne Foyer

MONDAY, FEBRUARY 6

07:00—08:00
Breakfast

Mezzanine 2
08:00—09:30
Welcome and Keynote Session (Joint)

Van Horne A/B
* Kevin V. Morris, Center for Gene Therapy, City of Hope, USA

* Gene W. Yeo, University of California, San Diego, USA

Thomas R. Cech, HHMI/University of Colorado, USA
Noncoding RNA-Protein Interactions: Telomerase and PRC2

Gerald F. Joyce, The Salk Institute, USA
Tertiary Structured RNAs as Potential Therapeutic Targets

Coffee Break

09:50—11:15
Noncoding RNAs and RNA-Protein Interactions (Joint)

Van Horne A/B
* Saba Valadkhan, Case Western Reserve University, USA

Gene W. Yeo, University of California, San Diego, USA
Large-Scale Assessment of the Functions and Targets of Hundreds of RNA Binding Proteins

Archa Fox, University of Western Australia, Australia
New Insights into NEAT1 Long Noncoding RNA and Paraspeckles

Sarah D. Diermeier, University of Otago, New Zealand
Short Talk: Mammary Tumor Associated RNAs (MaTARs) as Drivers of Tumor Cell Growth and Metastasis

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Mezzanine 2
13:00—22:00
Poster Viewing

Mezzanine 2
16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
Disease-Specific Noncoding RNAs: From Complex Genomic Interactions to Mechanism

Van Horne A/B
* John L. Rinn, University of Colorado Boulder, USA

Musa M. Mhlanga, University of Cape Town, South Africa
Higher Order Genome Architecture and LncRNAs Permit Robust Transcription of Immune Genes

Jane E. Freedman, University of Massachusetts Medical School, USA
Expression of Noncoding RNAs in Human Populations and Disease

Howard Y. Chang, Stanford University, USA
Genome Regulation by Long Noncoding RNAs

Eleonora Leucci, KU Leuven, Belgium
Short Talk: SAMMSON Coordinates Cell and Mitochondrial Ribosome Biogenesis to Promote Tumor Progression

17:00—19:00
Complete Characterization of RNP Proteomes: Coding and Noncoding RNAs

Van Horne C
* Jernej Ule, Francis Crick Institute & UCL, UK

Matthias W. Hentze, European Molecular Biology Laboratory, Germany
Smartphone Proteins Connecting Gene Expression and Metabolism

Marlene Oeffinger, Institut de Recherches Cliniques de Montreal, Canada
Correlative Proteome-RNome Analysis to Investigate Variant Interactomes along Gene Expression Pathways

Karla M. Neugebauer, Yale University, USA
Dynamic RNA-Protein Interactions and Nuclear Organization Support Zebrafish Embryogenesis

Eric L. Van Nostrand, University of California, San Diego, USA
Short Talk: The Landscape of Protein-RNA Interactions: Insights from eCLIP of 126 RNA Binding Proteins

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
19:30—22:00
Poster Session 1

Mezzanine 2

TUESDAY, FEBRUARY 7

07:00—08:00
Breakfast

Mezzanine 2
07:30—08:00
Poster Setup

Mezzanine 2
08:00—17:00
Poster Viewing

Mezzanine 2
08:00—11:15
Molecular Mechanisms and Functional Studies of Protein Interactions with Noncoding RNAs in Disease

Van Horne A/B
* Kevin V. Morris, Center for Gene Therapy, City of Hope, USA

John L. Rinn, University of Colorado Boulder, USA
Chromatin Environment, Transcriptional Regulation, and Splicing Distinguish lincRNAs and mRNAs

Ingrid Grummt, German Cancer Research Center, Germany
DNA:RNA Triple Helices: A Liaison between Noncoding RNAs and Chromatin

Coffee Break

Saba Valadkhan, Case Western Reserve University, USA
Immune Modulatory Noncoding RNAs in Disease

Charlie Bond, University of Western Australia, Australia
High-Resolution Structural Studies and Gel- and Filament-Forming Properties of Paraspeckle RNA-Binding Proteins

Kaveh Daneshvar, Harvard Medical School, USA
Short Talk: RNA-Aptamer Chimera Crosslinking and Pull-Down to Identify Proteins that Interact with the Long Noncoding RNA DIGIT

Meredith Corley, University of North Carolina at Chapel Hill, USA
Short Talk: An RNA Structure Mediated, Post-Transcriptional Model of alpha-1-antitrypsin Expression

08:00—11:00
Protein-RNA Localization

Van Horne C
* Gene W. Yeo, University of California, San Diego, USA

Eric Lecuyer, Institut de Recherches Cliniques de Montreal, Canada Joint Institute, Canada
Systematic Characterization of the Subcellular Distribution Properties of Human RNA Binding Proteins

Roy R. Parker, HHMI/University of Colorado, USA
Stress Granules, P-Bodies

Markus Landthaler, Max-Delbrück-Center for Molecular Medicine, Germany
Exploring Global Changes in Protein-mRNA Interactions

Coffee Break

Christine Mayr, Memorial Sloan Kettering Cancer Center, USA
3'UTR-Mediated Protein-Protein Interactions Regulate Protein Functions

Jessica Sheu-Gruttadauria, The Scripps Research Institute, USA
Short Talk: Phase Separation Facilitates MicroRNA Mediated Gene Silencing

11:15—12:00
Lunch

Mezzanine 2
12:00—14:30
Poster Session 2

Mezzanine 2
14:30—16:30
Workshop 1: Recent Observations of Noncoding RNAs, from Function to Therapeutic Modulation

Van Horne A/B
* Gregory J. Goodall, SA Pathology, Australia

* Ling-Ling Chen, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China

Paulo P. Amaral, University of Cambridge, UK
Genomic Positional Conservation Identifies Topological Anchor Point (tap)RNAs Linked to Developmental Loci

Orna Issler, Mount Sinai School of Medicine, USA
The Role of Long Non-Coding RNAs in Depression

Martin Sauvageau, Montreal Clinical Research Institute - IRCM, Canada
The Tug1 lncRNA Locus is Essential for Male Fertility and Harbors a cis Repressive Element

Igor Ulitsky, Weizmann Institute of Science, Israel
A Subset of Conserved Mammalian Long Noncoding RNAs are Fossils of Ancestral Protein-Coding Genes

Mohamed Fareh, Delft University of Technology, Netherlands
Single-Molecule Fluorescence Reveals how Dicer-TRBP Recognizes Precursor microRNA in Crowded Cellular Environment

Benjamin R. Hawley, Weill Cornell Medicine, USA
A Novel Role for the microRNA Biogenesis Apparatus in the Repair of DNA Double-Strand Breaks

Puri Fortes, Foundation for Applied Medical Research, Spain
Antiviral Long Non-Coding RNA EGOT Functions as a Proviral Factor after HCV Infection

Kaitlyn Rinehold Scacalossi, New York University, USA
LncRNA CHROME Interacts with DNA to Regulate Transcription of Inflammatory Genes

14:30—16:30
Workshop 1: RNA Localization in Development and Disease

Van Horne C
* Karla M. Neugebauer, Yale University, USA

Sahar Soltanieh, Institut de Recherches Cliniques de Montréal, Canada
Defining the RNA Binding Protein Repertoire of Stress Granules

Michaela Müller-McNicoll, Goethe University Frankfurt, Germany
Cell Type-Specific NucleoCcytoplasmic Shuttling of SR Proteins Reveals Distinct Constellations of RNA-and Protein-Interactors

Takeshi Chujo, Hokkaido University, Japan
Remarkable Semi-Extractability as the Hallmark of Nuclear Body-Associated Architectural Long Noncoding RNAs

Anastasios Vourekas, University of Pennsylvania, USA
The Role of RNA Helicase DDX3X in the Activation of HIV Replication in Latently Infected T Cells

Arnaud Hubstenberger, Institute of Biology Valrose, France
P-Bodies Condense Coordinately Repressed mRNA Regulons

Lilli Olgeiser, Heinrich-Heine-University, Germany
Transcriptome-Wide Analysis of Endosomal mRNP Transport

Louis Philip Benoit Bouvrette, Universite de Montreal, Canada
Systematic Characterization of Subcellular RNA Localization Through Fractionation-Sequencing

Eric T. Wang, University of Florida, USA
Impeding Transcription of Expanded Microsatellite Repeats by dCas9

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
Molecular Mechanisms of ncRNA-Protein Interactions in Disease

Van Horne A/B
* Archa Fox, University of Western Australia, Australia

Judy Lieberman, Harvard University, USA
Shooting the Messenger: Rapid and Global mRNA Decay in Apoptosis

Marianne Farnebo, Karolinska Institutet, Sweden
Role of RNA Processing Factors in DNA Repair

Gregory J. Goodall, SA Pathology, Australia
Circular RNAs Regulated during Epithelial-Mesenchymal Transition

Tetsuro Hirose, Hokkaido University, Japan
Short Talk: Liquid-Liquid Phase Separation and Paraspeckle Formation Induced by the Specific Region of NEAT1 lncRNA

17:00—19:15
Protein-RNA Recognition: Structural, Biochemical and Computational

Van Horne C
* Zefeng Wang, CAS-MPG Partner Institute of Computational Biology, China

Frédéric H.T. Allain, ETH Zurich, Switzerland
Structures of Protein RNA Complexes using Hybrid Structural Approaches

Clara L. Kielkopf, University of Rochester Center for RNA Biology, USA
Structures of pre-mRNA Splicing Factors in Cancer

Joel R. Neilson, Baylor College of Medicine, USA
CELF1 is a Central Node in Post-transcriptional Regulatory Programs Underlying EMT

Linnea Jansson, University of California, Santa Cruz, USA
Short Talk: Probing the Structure and Function of Human Telomerase

Ralf Ficner, University of Goettingen, Germany
Short Talk: Structural Insights into the Mechanism of DEAH-box RNA Helicases

19:00
On Own for Dinner


WEDNESDAY, FEBRUARY 8

07:00—08:00
Breakfast

Mezzanine 2
08:00—11:15
Nucleic Acid-Based Strategies to Disrupt ncRNA and Gene Interactions

Van Horne A/B
* Judy Lieberman, Harvard University, USA

Kevin V. Morris, Center for Gene Therapy, City of Hope, USA
Functional Roles of RNA in Nucleotide Content, Selection and Gene Evolution

Claes Wahlestedt, University of Miami, Miller School of Medicine, USA
Gene Upregulation by Targeting Long Noncoding RNAs

Coffee Break

David R. Corey, University of Texas Southwestern Medical Center, USA
Control of lncRNA Function by Small RNAs

Kim A. Lennox, Integrated DNA Technologies, USA
Optimal Knockdown of Long Noncoding RNAs Is Dependent on Subcellular Localization: RNAi versus Antisense

Ben Berkhout, University of Amsterdam, Academic Medical Center, Netherlands
Short Talk: A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes all Infectious Provirus in Infected T Cell Cultures

Ankit Bhatta, University of Massachusetts Medical School, USA
Short Talk: An Immune Regulated Annotated Long Noncoding RNA Encodes a Mitochondrial Micropeptide

08:00—11:00
Coding and Noncoding RNP Complexes

Van Horne C
* Eric Lecuyer, Institut de Recherches Cliniques de Montreal, Canada Joint Institute, Canada

Susan Baserga, Yale University School of Medicine, USA
Using Cryo-Electron Microscopy to Discover Box C/D s(no)RNP Structure

Jeannie T. Lee, Massachusetts General Hospital / Harvard Medical School, USA
Interaction of RNA with Polycomb Complexes: Regulation, Function and Cellular Consequences

Coffee Break

Jeffrey A. Chao, Friedrich Miescher Institute for Biomedical Research, Switzerland
Imaging the Life and Death of mRNAs in Single Cells

Melissa Jurica, University of California, Santa Cruz, USA
The Dynamic Architecture of Human Spliceosomes

Olivia Rissland, University of Colorado School of Medicine, USA
Short Talk: Widespread Reorganization of mRNA-Protein Complexes at the Mid-Blastula Transition

11:15—14:30
On Own for Lunch

11:15—13:00
Poster Setup

Mezzanine 2
13:00—22:00
Poster Viewing

Mezzanine 2
14:30—16:30
Workshop 2: Synthetic Nucleic Acids, Targeted Approaches to Disrupting Noncoding RNA Pathways in Disease

Van Horne A/B
* Tetsuro Hirose, Hokkaido University, Japan

* David R. Corey, University of Texas Southwestern Medical Center, USA

Jan Gorodkin, University of Copenhagen, Denmark
From Fast Computational Screen for RNA-RNA Interactions to siRNA Off-Target Prediction

John Liu, University of California, San Francisco, USA
Genome-Scale CRISPRi-Based Screening of lncRNAs Reveals Radiation Sensitizers for Glioma Therapy

Guia Guffanti, Harvard Medical School, USA
Differential Expression of Long Non-Coding RNA GAS5 in Post-Traumatic Stress Disorder

Claudia Lang, Plant and Food Research, New Zealand
Genetic Variants of Plant MicroRNA miR168a Can Affect Regulatory Function with the Human Low Density Lipoprotein Receptor Adaptor Protein 1 (LDLRAP1) Transcript in vitro

Li Yang, CAS-MPG Partner Institute for Computational Biology, China
Alternative Back-Splicing Landscape of circRNAs

Jennifer Perez Boza, University of Liège, Belgium
The RNA Sub-Classes Distribution of Small RNAs Differs Between Cells and Exosomes

14:30—16:30
Workshop 2: Coupling between Transcription and Post-Transcriptional Processes

Van Horne C
* Markus Landthaler, Max-Delbrück-Center for Molecular Medicine, Germany

Yael Mandel-Gutfreund, Technion – Israel Institute of Technology, Israel
Revealing the Role of Dual DNA and RNA Binding Proteins in Human Embryonic Stem Cells

Philipp Neumann, Goethe-University, Germany
The Antisense Transcript of GATA6 Interacts With The H3K4me3 Deaminase LOXL2 and Epigenetically Regulates Endothelial Gene Expression

Ivanka D. Kamenova, Nature Protocols, UK
Co-Translational Assembly of Transcription Complexes

Giorgia Benegiamo, The Salk Institute for Biological Studies, USA
NONO Coordinates Pre-mRNA Processing with Fasting/Feeding Cycles in the Mouse Liver

William J. Martin, Vanderbilt University, USA
Structure-Specific Recognition of a G-Quadruplex RNA by the Histone Demethylase LSD1

John A. Smolka, University of California, Davis, USA
Proteomic Identification and Functional Investigation of Novel Factors and Pathways in RNA:DNA Hybrid Metabolism

Wei Zhang, Albany Medical College, USA
A Vascular Smooth Muscle-Enriched Long Non-coding RNA (MELRI) Interacts with Myocardin-Related Transcription Factor A and Promotes Inflammation

Nabieh Ayoub, Technion -Israel Institute of Technology, Israel
High-Throughput Mapping of the RNA Interacting Molecules of KDM4 Lysine Demethylases

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
RNA and DNA Control of Genes and Gene Networks in Disease

Van Horne A/B
* Adrian R. Krainer, Cold Spring Harbor Laboratory, USA

Ling-Ling Chen, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China
The Diversity of Sno-processed lncRNAs and their Roles in Gene Regulation

Jean-Jacques Toulme, University of Bordeaux, France
Aptamer-Based Riboswitches

Jacob M. Berlin, Beckman Research Institute of City of Hope, USA
Small Molecule Targeting of Regulatory lncRNAs

Stuart F.J. Le Grice, NCI, National Institutes of Health, USA
Short Talk: Small Molecule Targeting of KSHV Polyadenylated Nuclear RNA (PAN)

17:00—19:15
RNA Landscape and Conformation at Scale: Interaction and Function

Van Horne C
* Jeffrey A. Chao, Friedrich Miescher Institute for Biomedical Research, Switzerland

Robert Spitale, University of California, Irvine, USA
Chemo-Transcriptomic Methods to Measure RNA Structure inside Living Cells

Yue Wan, Genome Institute of Singapore, Singapore
In vivo Mapping of Eukaryotic RNA Interactomes Reveals Principles of Higher-order Organization and Regulation

Jernej Ule, Francis Crick Institute & UCL, UK
Exon Junction Complex Inhibits Recursive Splicing of Canonical Exons

Mihir Metkar, University of Massachusetts Medical School, USA
Short Talk: Understanding Higher Order Structure of Spliced RNPs

Yoosik Kim, Korea Advanced Institute of Science and Technology, South Korea
Short Talk: PKR is Activated by Mitochondrial ncRNAs and Serves as a Coordinator of Mitochondrial-Nuclear Communication

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
19:30—22:00
Poster Session 3

Mezzanine 2

THURSDAY, FEBRUARY 9

07:00—08:00
Breakfast

Mezzanine 2
08:00—11:15
Synthetic RNAs: From Evolution to Catalysis to Functional Gene Targeting

Van Horne A/B
* Ryszard Kole, Ercole Biotech Consulting, USA

Paloma Giangrande, Moderna, USA
RNA Aptamer-Conjugates: Targeting Disease-Relevant Genes and RNAs

Muthiah Manoharan, Alnylam Pharmaceuticals, Inc., USA
RNAi Therapeutics: From Discovery to Applications

Coffee Break

Adrian R. Krainer, Cold Spring Harbor Laboratory, USA
Mechanism-Based Antisense Therapeutics Targeting Splicing or NMD

Paolo G. V. Martini, Moderna, USA
Messenger RNA Therapy for Monogenic Disorders

Aline Koch, Justus Liebig University, Germany
Short Talk: RNA Spray Fights Fungus

Brian H. Johnston, Somagenics Inc., USA
Short Talk: Local delivery of sshRNAs Accelerate Wound Healing in Diabetic Mice

08:00—11:00
RNA Modifications of Noncoding and Coding RNAs

Van Horne C
* Melissa Jurica, University of California, Santa Cruz, USA

Jin Billy Li, Stanford University, USA
New Insights of RNA Editing Regulation

Jeremy E. Wilusz, University of Pennsylvania, USA
Regulation of MALAT1 and Other Non-Polyadenylated RNAs

Coffee Break

Wendy V. Gilbert, Massachusetts Institute of Technology, USA
Regulated RNA Modifications

Chuan He, University of Chicago, USA
RNA Methylation in Gene Expression Regulation

Marie Ohman, Stockholm University, Sweden
Short Talk: RNA Editing Regulates Synaptic miRNAs

11:15—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
Therapeutic Approaches to Disrupting or Mimicking lncRNA Function

Van Horne A/B
* Paloma Giangrande, Moderna, USA

Stefano Gustincich, Italian Institute of Technology, Italy
SINEUPs: A New Class of Natural and Synthetic Antisense Long Noncoding RNAs that Activate Translation

Ryszard Kole, Ercole Biotech Consulting, USA
PMO Targeting of mRNAs in Human Disease

Fabio Romerio, University of Maryland School of Medicine, USA
The HIV-1 Antisense Transcript AST Promotes Latency by Recruiting PRC2 to the 5'LTR

Jonathan T. Sczepanski, Texas A&M University, USA
Short Talk: Mirror-Image Aptamers with Expanded Functionality for Targeting RNA Structures

17:00—19:15
Molecular Engineering of RNA and Protein Complexes

Van Horne C
* Robert Spitale, University of California, Irvine, USA

Zefeng Wang, CAS-MPG Partner Institute of Computational Biology, China
Manipulation of RNA Metabolism Using Engineered Proteins

Samie Jaffrey, Weill Medical College of Cornell University, USA
Imaging Cellular Messengers with Genetically Encoded Sensors Composed of Circular RNA

Stephen N. Floor, University of California, Berkeley, USA
Measuring and Engineering Translation at Transcript Isoform Resolution

Kinjal Ashokbhai Patel, National Institute of Pharmaceutical Education and Research, India
Short Talk: Interaction of RNA Aptamers with Mutant Huntingtin Protein: Implication for Protein Aggregation and Mitochondrial Function in Huntington’s Disease

Sarah Denny, Stanford University, USA
Short Talk: High-throughput, Quantitative Characterization of Modular Elements of RNA Tertiary Structure

19:00—19:15
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Van Horne A/B
19:15—19:30
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Van Horne C
19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Mezzanine 2

FRIDAY, FEBRUARY 10

 
Departure


*Session Chair †Invited, not yet responded.


We gratefully acknowledge support for this conference from:


Directors' Fund

These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.

Keystone Symposia thanks our Sponsors(s) for generously supporting this meeting:

Cell Research Ionis Pharmaceuticals, Inc.
Merck & Co., Inc. Moderna Therapeutics

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13CA213553-01

Funding for this conference was made possible (in part) by 1R13CA213553-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We gratefully acknowledge additional support for this conference from:

Exiqon A/S Integrated DNA Technologies
LEXOGEN RNA Therapeutics Research, Roche Innovation Center Copenhagen

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Elpidera LLC, a Moderna Venture


Integrated DNA Technologies

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations

If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Corporate Relations, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179